At the end of this session, participants will be able to:

• Describe the clinical management of post injection infectious endophthalmitis and integrate evidence-based best practices for risk mitigation.
• Describe different strategies for the management of vitreous floaters and identify the structural and functional differences in outcomes with each treatment strategy.
• Describe the risk of ocular hypertension and glaucoma in patient receiving ongoing intravitreal injection therapy and integrate prophylactic strategies for at-risk patients.

CANMEDS ROLES:Medical Expert, Scholar